Skip to main content
. 2019 Dec 16;20(24):6337. doi: 10.3390/ijms20246337
PBMC peripheral blood mononuclear cell
MHC major histocompatibility complex
DC dendritic cell
irAE immune-related adverse events
ICI immune checkpoint inhibitors
HER2 Human epidermal growth factor receptor 2
IHC immunohistochemistry
PD-L1 programmed-death-L1
NOD scid nonobese diabetic severe combined immunodeficient
HSC hematopoietic stem cells
NOG NOD/Shi-scid-IL2Rγnull
NSG NOD scid gamma
GVHD graft-versus-host disease